000 03892nam a22004575i 4500
001 60405
005 20200226102452.0
007 cr nn 008mamaa
008 170624s2017 gw | s |||| 0|eng d
020 _a9783319544939
_9978-3-319-54493-9
024 7 _a10.1007/978-3-319-54493-9
_2doi
035 _a(DE-He213)978-3-319-54493-9
050 4 _aRD651-678
072 7 _aMNK
_2bicssc
072 7 _aMED085000
_2bisacsh
072 7 _aMED062000
_2bisacsh
082 0 4 _a616.994
_223
245 1 0 _aManagement of Differentiated Thyroid Cancer
_h[electronic resource] /
_cedited by Anne T. Mancino, Lawrence T. Kim.
264 1 _aCham :
_bSpringer International Publishing :
_bImprint: Springer,
_c2017.
300 _aXIII, 320 p. 88 illus., 64 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aThe Rising Incidence of Thyroid Cancer: Contributions from Healthcare Practice and Biologic Risk Factors -- Molecular Genetics of Thyroid Cancer -- Evaluation of a thyroid nodule -- Pathologic diagnosis of thyroid cancer -- Molecular Diagnostic Approaches and their Clinical Utility -- Clinical Presentation and Diagnosis of Papillary Thyroid Cancer -- Clinical Presentation and Diagnosis of Follicular Thyroid Cancer -- Clinical Presentation and Diagnosis of Hürthle cell Thyroid Cancer -- High Risk and Poorly Differentiated Thyroid Cancer -- Pediatric Thyroid Cancer -- Active Surveillance as the Initial Course of Action in low-risk papillary microcarcinoma -- Surgical treatment of papillary and follicular thyroid cancer -- Lymph node dissection for differentiated thyroid cancer -- The Debate For Elective Lymph Node Dissection in Papillary Thyroid Carcinoma -- Debate: Pro and Con Elective Lymph Node Dissection -- Differentiated Thyroid Cancer – Prognostic and Risk Assessment Systems -- Radioactive Iodine as Adjuvant or Systemic Treatment -- Considerations in thyrotropin stimulating hormone suppression in individuals with differentiated thyroid cancer -- IMAGING MODALITIES IN THE DIAGNOSIS OF RECURRENT OR METASTATIC THYROID CANCER -- Operative Treatment of Recurrent or Metastatic Disease -- Local and Systemic Treatment of Unresectable Disease -- Surveillance Strategies After Initial Treatment of Differentiated Thyroid Cancer.
520 _aThis text provides a comprehensive, state-of-the art review of this field, and serves as a valuable resource for clinicians, surgeons and researchers with an interest in thyroid cancer. The book reviews new data about molecular genetics and molecular diagnostic approaches, covers diagnosis and treatment of localized disease, and conventional and newer therapies for dealing with recurrent and metastatic disease. Areas of controversy, with expert opinions from both outlooks, are also covered. Management of Differentiated Thyroid Cancer serves as a very useful resource for physicians and researchers dealing with, and interested in, this challenging malignancy. It provides a concise yet comprehensive summary of the current status of the field that will help guide patient management and stimulate investigative efforts. All chapters are written by experts in their fields and include the most up-to-date scientific and clinical information.
650 0 _aMedicine.
650 0 _aEndocrinology.
650 0 _aSurgical oncology.
650 1 4 _aMedicine & Public Health.
650 2 4 _aSurgical oncology.
650 2 4 _aEndocrinology.
700 1 _aMancino, Anne T.
_eeditor.
700 1 _aKim, Lawrence T.
_eeditor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9783319544922
856 4 0 _uhttp://dx.doi.org/10.1007/978-3-319-54493-9
912 _aZDB-2-SME
999 _c5039
_d5039